×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
KYTX – kyverna therapeutics, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
KYTX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/17
07:38 am
kytx
Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR) - Grabar Law Office Is Investigating Claims on Your Beh
Medium
Report
Notice to Long-Term Shareholders of Kyverna Therapeutics, Inc. (NASDAQ: KYTX); Methode Electronics, Inc. (NYSE: MEI); ModivCare, Inc. (NASDAQ: MODV); and Monolithic Power Systems, Inc. (NASDAQ: MPWR) - Grabar Law Office Is Investigating Claims on Your Beh
4/3
08:03 am
kytx
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) had its price target lowered by analysts at HC Wainwright from $6.00 to $4.00. They now have a "neutral" rating on the stock.
Low
Report
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) had its price target lowered by analysts at HC Wainwright from $6.00 to $4.00. They now have a "neutral" rating on the stock.
4/1
08:44 am
kytx
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) had its price target lowered by analysts at Morgan Stanley from $40.00 to $20.00. They now have an "overweight" rating on the stock.
Low
Report
Kyverna Therapeutics, Inc. (NASDAQ: KYTX) had its price target lowered by analysts at Morgan Stanley from $40.00 to $20.00. They now have an "overweight" rating on the stock.
3/27
04:45 pm
kytx
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
High
Report
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results [Yahoo! Finance]
3/27
04:02 pm
kytx
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
High
Report
Kyverna Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results
3/3
04:40 pm
kytx
Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference [Yahoo! Finance]
Low
Report
Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference [Yahoo! Finance]
3/3
04:05 pm
kytx
Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference
Low
Report
Kyverna Therapeutics to Present at the Leerink Partners Global Biopharma Conference
2/11
12:04 am
kytx
What Makes Kyverna Therapeutics, Inc. (KYTX) a New Buy Stock [Yahoo! Finance]
Medium
Report
What Makes Kyverna Therapeutics, Inc. (KYTX) a New Buy Stock [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
11/13/2024
04:14 pm
kytx
kyverna therapeutics, inc.
MISS
Report
-7.0%
kyverna therapeutics, inc.
8/12/2024
04:08 pm
kytx
kyverna therapeutics, inc.
BEAT
Report
5.1%
kyverna therapeutics, inc.
8/12/2024
04:08 pm
kytx
kyverna therapeutics, inc.
BEAT
Report
5.1%
kyverna therapeutics, inc.
8/12/2024
04:08 pm
kytx
kyverna therapeutics, inc.
BEAT
Report
4.2%
kyverna therapeutics, inc.
Date
Time
Symbol
Headline
Impact
4/16
06:02 am
kytx
Form EFFECT Kyverna Therapeutics,
Medium
Report
Form EFFECT Kyverna Therapeutics,
4/15
05:43 pm
kytx
Form 4 Kyverna Therapeutics, For: Apr 11 Filed by: Biddle Warner Weston
Medium
Report
Form 4 Kyverna Therapeutics, For: Apr 11 Filed by: Biddle Warner Weston
4/15
05:42 pm
kytx
Form 4 Kyverna Therapeutics, For: Apr 11 Filed by: Jones Ryan Alexander
Medium
Report
Form 4 Kyverna Therapeutics, For: Apr 11 Filed by: Jones Ryan Alexander
4/15
05:40 pm
kytx
Form 4 Kyverna Therapeutics, For: Apr 11 Filed by: Walker Karen Marie
Medium
Report
Form 4 Kyverna Therapeutics, For: Apr 11 Filed by: Walker Karen Marie
4/15
04:39 pm
kytx
Form 424B5 Kyverna Therapeutics,
Medium
Report
Form 424B5 Kyverna Therapeutics,
4/14
04:08 pm
kytx
Form ARS Kyverna Therapeutics, For: Dec 31
High
Report
Form ARS Kyverna Therapeutics, For: Dec 31
4/14
04:05 pm
kytx
Form DEFA14A Kyverna Therapeutics,
High
Report
Form DEFA14A Kyverna Therapeutics,
4/14
04:03 pm
kytx
Form DEF 14A Kyverna Therapeutics, For: May 29
High
Report
Form DEF 14A Kyverna Therapeutics, For: May 29
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: